ENTERA BIO LTD (ENTXW)
Institutional ownership reported to the SEC as of Q1 2023, across 17 quarters.
1
Reporting holders
$81
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS Group AG | $81 | 3,100 | 0.00% | 2q | +148.8% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 1 | $81 | 3,100 | 0 | 1 | 0 | 0.0% |
| Q4 2022 | 1 | $37 | 1,246 | 1 | 0 | 0 | 0.0% |
| Q2 2022 | 1 | $1.0K | 10,880 | 0 | 0 | 1 | 0.0% |
| Q1 2022 | 1 | $4.0K | 12,254 | 0 | 1 | 0 | 0.0% |
| Q4 2021 | 3 | $17.0K | 59,308 | 2 | 0 | 1 | 0.0% |
| Q3 2021 | 2 | $24.0K | 46,179 | 0 | 0 | 1 | 0.0% |
| Q2 2021 | 3 | $160.0K | 159,954 | 2 | 1 | 0 | 0.0% |
| Q1 2021 | 2 | $27.0K | 54,389 | 1 | 0 | 1 | 0.0% |
| Q4 2020 | 1 | $25.0K | 288,725 | 0 | 0 | 0 | 0.0% |
| Q3 2020 | 1 | $40.0K | 284,914 | 0 | 0 | 1 | 0.0% |
| Q2 2020 | 2 | $83.0K | 308,385 | 1 | 1 | 0 | 0.0% |
| Q1 2020 | 1 | $1.0K | 4,788 | 0 | 1 | 0 | 0.0% |
| Q4 2019 | 3 | $118.0K | 284,313 | 1 | 1 | 0 | 54.2% |
| Q3 2019 | 2 | $169.0K | 14,606 | 0 | 1 | 0 | 95.9% |
| Q2 2019 | 2 | $135.0K | 14,030 | 0 | 1 | 0 | 95.6% |
| Q1 2019 | 3 | $293.0K | 18,336 | 2 | 1 | 0 | 95.2% |
| Q4 2018 | 1 | $2.0K | 4,263 | 0 | 0 | 0 | 0.0% |